Experts encourage early influenza vaccination in children to reduce severe illness and hospitalization, especially among medically vulnerable and underserved populations.
The U.S. Department of Health and Human Services has adopted a CDC advisory panel recommendation to remove thimerosal from all influenza vaccines, transitioning entirely to mercury-free, single-dose formulations.
Following national rollout, UK data provide early post-licensure evidence supporting maternal RSV vaccination as a real-world strategy to lower infant hospital admissions.
A review of 10 studies with 233 patients found limited benefits and potential safety risks associated with mouth taping for obstructive sleep apnea and mouth breathing during sleep.
A randomized clinical trial in 92 children aged 3 to 17 found inhaled isoflurane as effective as intravenous midazolam in maintaining sedation during mechanical ventilation, with reduced opioid use and quicker extubation times.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A large clinical trial in Europe showed that a single dose of nirsevimab reduced infant hospitalizations for RSV-associated lower respiratory tract infections by over 80% over a six-month period.
A new study analyzing over a decade of national health surveys, electronic records, and international data shows a consistent rise in chronic conditions, obesity, emotional symptoms, and mortality rates among children and adolescents in the U.S..